Search

  • HOME
  • Search
Original Articles
13731
Efficacy and Safety of a Fixed Combination of Bimatoprost (0.03% w/v) and Timolol (0.5% w/v) for Patients with Open-angle Glaucoma
Jae Jin Cho, Jae Yeun Lee
J Korean Ophthalmol Soc. 2023;64(3):232-238.   Published online March 15, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
13651
Add-on Effect of Prostaglandin Analogues in Dorzolamide/Timolol Fixed Combination Treated Primary Open Angle Glaucoma Patients
Jae Hoon Lee, Sang Wook Jin
J Korean Ophthalmol Soc. 2022;63(8):700-706.   Published online August 15, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Effect of Bimatoprost on the Permeability of Trabecular Meshwork Cell Monolayer.
Bi Chang, Jae Woo Kim
J Korean Ophthalmol Soc. 2015;56(4):586-591.   Published online April 15, 2015
PDFPDF    
Clinical Course of Bimatoprost-induced Periocular Skin Hyperpigmentation after Stopping Bimatoprost Treatment.
Dong Wook Lee
J Korean Ophthalmol Soc. 2007;48(8):1082-1087.   Published online August 31, 2007
PDFPDF    
Case Reports
Two Cases of Deepening of the Upper Lid Sulcus from Topical Bimatoprost Therapy.
Joong Won Lee, Dae Yune Kim, Yong Kil Lee
J Korean Ophthalmol Soc. 2007;48(2):332-336.   Published online February 28, 2007
PDFPDF    
Original Articles
The Short Term Effects of Bimatoprost on Optic Nerve Head and Peripapillary Retinal Blood Flow.
Sun Woong Kim, Chan Yun Kim, Gong Je Seong
J Korean Ophthalmol Soc. 2004;45(8):1322-1329.   Published online August 1, 2004
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next